Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL and PTSC

"Why would TPL decide to merge with PTSC who has 400 million outstanding shares?"

By gettting 200 million shares for themselves and not having to issue any to the public, we are already issued. The float would be really cut because Moore and the Lekrones would have millions of shares to keep for themselves. If and when divys are issued, wow guess who would get most the cash.

I believe it would be much better than going public on their own, and gaining the staf to manage the sec details allready done and in place.

Like I said to SGE , it would be just as hard , however I was thinking about how much more everyone do and have with the whole MMP mount not just half.

Just my thoughts.

Good Luck to us any way the cookie crumbles

Share
New Message
Please login to post a reply